IMMP2L and prostate carcinoma: In agreement with these publications, our experiments showed that mGPDH had only one cleavage site and that it was after Ala42 (Figure 2C) most probably by IMMP2L peptidase that we also found significantly increased in the prostate cancer LNCaP cell line (Figure 2D).